NYXOAH SA (NYXH.BR) Stock Price, Forecast & Analysis

Europe • Euronext Brussels • EBR:NYXH • BE0974358906

3.94 EUR
+0.01 (+0.25%)
Last: Feb 6, 2026, 05:29 PM

NYXH.BR Key Statistics, Chart & Performance

Key Statistics
Market Cap169.54M
Revenue(TTM)5.64M
Net Income(TTM)-83.57M
Shares43.03M
Float26.86M
52 Week High11.15
52 Week Low3.84
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-2.24
PEN/A
Fwd PEN/A
Earnings (Next)05-12
IPO2020-09-18
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
NYXH.BR short term performance overview.The bars show the price performance of NYXH.BR in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30

NYXH.BR long term performance overview.The bars show the price performance of NYXH.BR in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of NYXH.BR is 3.94 EUR. In the past month the price decreased by -8.6%. In the past year, price decreased by -62.03%.

NYXOAH SA / NYXH Daily stock chart

NYXH.BR Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

NYXH.BR Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to NYXH.BR. Both the profitability and financial health of NYXH.BR have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

NYXH.BR Financial Highlights

Over the last trailing twelve months NYXH.BR reported a non-GAAP Earnings per Share(EPS) of -2.24. The EPS decreased by -30.42% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -89.29%
ROE -164.01%
Debt/Equity 0.4
Chartmill High Growth Momentum
EPS Q2Q%-27.02%
Sales Q2Q%55.77%
EPS 1Y (TTM)-30.42%
Revenue 1Y (TTM)10.96%

NYXH.BR Forecast & Estimates

14 analysts have analysed NYXH.BR and the average price target is 9.56 EUR. This implies a price increase of 142.7% is expected in the next year compared to the current price of 3.94.

For the next year, analysts expect an EPS growth of -21.84% and a revenue growth 48.25% for NYXH.BR


Analysts
Analysts81.43
Price Target9.56 (142.64%)
EPS Next Y-21.84%
Revenue Next Year48.25%

NYXH.BR Ownership

Ownership
Inst Owners17.27%
Ins Owners19.98%
Short Float %N/A
Short RatioN/A

NYXH.BR Competitors/Peers

The largest stocks on the EU markets in the "Health Care Equipment" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
2M6 MEDTRONIC PLC16.87113.317B
1MDT MEDTRONIC PLC16.13108.304B
SHL SIEMENS HEALTHINEERS AG17.3848.053B
1PHIA KONINKLIJKE PHILIPS NV16.2723.842B
PHIA KONINKLIJKE PHILIPS NV16.2923.669B
PHI1 KONINKLIJKE PHILIPS NV15.8823.264B
BIM BIOMERIEUX18.9611.54B
DIA DIASORIN SPA17.974.173B
OBCK OTTOBOCK SE & CO KGAA19.573.916B
1AFX CARL ZEISS MEDITEC AG - BR14.52.513B

Related stock screener links

View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Brussels Exchange | Find stocks with similar TA and Setup ratings on the EuroNext exchanges | Find stocks with similar Fundamental rating on the EuroNext exchanges | Find the competitors with the best technical ratings on the EuroNext exchanges | Find the competitors with the best fundamentals on the EuroNext exchanges | Find the competitors with the best valuation on the EuroNext exchanges | Find the competitors with the best dividend on the EuroNext exchanges | Find the competitors with the best analyst ratings on the EuroNext exchanges

About NYXH.BR

Company Profile

NYXH logo image Nyxoah SA is a medical technology company, which engages in the development and commercialization of solutions to treat Obstructive Sleep Apnea (OSA). The company is headquartered in Mont-Saint-Guibert, Brabant-Wallon and currently employs 184 full-time employees. The company went IPO on 2020-09-18. The firm focuses on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The system consists of a neurostimulator, which is implanted close to the nerve of the tongue, as well as an activation chip, which is connected to a disposable patch and is positioned every night by the patient under the chin.

Company Info

NYXOAH SA

Rue Edouard Belin 12

Mont-Saint-Guibert BRABANT-WALLON BE

Employees: 184

NYXH Company Website

NYXH Investor Relations

Phone: 3226121755

NYXOAH SA / NYXH.BR FAQ

What does NYXH do?

Nyxoah SA is a medical technology company, which engages in the development and commercialization of solutions to treat Obstructive Sleep Apnea (OSA). The company is headquartered in Mont-Saint-Guibert, Brabant-Wallon and currently employs 184 full-time employees. The company went IPO on 2020-09-18. The firm focuses on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The system consists of a neurostimulator, which is implanted close to the nerve of the tongue, as well as an activation chip, which is connected to a disposable patch and is positioned every night by the patient under the chin.


Can you provide the latest stock price for NYXOAH SA?

The current stock price of NYXH.BR is 3.94 EUR. The price increased by 0.25% in the last trading session.


What is the dividend status of NYXOAH SA?

NYXH.BR does not pay a dividend.


What is the ChartMill technical and fundamental rating of NYXH stock?

NYXH.BR has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


Can you provide the number of employees for NYXOAH SA?

NYXOAH SA (NYXH.BR) currently has 184 employees.


What is NYXOAH SA worth?

NYXOAH SA (NYXH.BR) has a market capitalization of 169.54M EUR. This makes NYXH.BR a Micro Cap stock.